Android Apple

ACADIA Pharmaceuticals Inc. (ACAD) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$17.04

north_east $0.17 (1.01%)
Day's range
$16.62
Day's range
$17.06

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/07/2024 Morgan Stanley Jeffrey Hung $20.00 $18.85   6.1%
06/26/2024 BMO Capital Keith Tapper $31.00 $15.50   100%
05/09/2024 H.C. Wainwright Andrew Fein $27.00 $17.13   57.62%
05/09/2024 Robert W. Baird Joel Beatty $28.00 $17.13   63.46%
05/09/2024 Mizuho Securities Uy Ear $21.00 $17.13   22.59%
04/30/2024 UBS Ashwani Verma $27.00 $17.10   57.89%
03/12/2024 UBS Ashwani Verma $33.00 $19.98   65.17%
03/12/2024 Oppenheimer Jay Olson $19.00 $19.98   -4.9%
03/12/2024 Needham Ami Fadia $32.00 $19.98   60.16%
03/12/2024 Canaccord Genuity Sumant Kulkami $33.00 $19.98   65.17%
03/11/2024 JMP Securities Jason Butler $39.00 $19.98   95.2%
01/24/2024 Needham Ami Fadia $37.00 $27.19   36.08%
No analyst forecast available for this stock.

ACADIA Pharmaceuticals Inc. FAQ's

What analysts cover ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. has been rated by research analysts at Morgan Stanley, BMO Capital, H.C. Wainwright, Robert W. Baird, Mizuho Securities, UBS in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.